Skip to main content

Nexus Pharmaceuticals Launches Fluorescein 2 mL

Nexus Pharmaceuticals, LLC is expanding their Fluorescein dosage options to include Fluorescein Injection, USP 25% in a 2 mL vial alongside Fluorescein Injection, USP 10% in a 5 mL vial. Nexus is committed to enhancing the availability of Fluorescein across the optometry market.

Fluorescein 2 mL and 5 mL are available in cartons of ten. Order your supply of 2 mL Fluorescein Injection, USP 25% directly through your Wholesalers or from Customer Service at (888) 806-4606.

Unit of sale NDC: 14789-0123-05

  • Cencora – 10298239
  • Cardinal – 5977483
  • McKesson – 3020054
  • Morris & Dickson - 594374

About Nexus Pharmaceuticals, LLC: Nexus Pharmaceuticals, LLC., a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Nexus ensures that its high-quality drug products fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they’re needed most.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  211.36
-1.43 (-0.67%)
AAPL  250.14
-8.72 (-3.37%)
AMD  216.87
-3.31 (-1.51%)
BAC  49.94
-0.12 (-0.24%)
GOOG  299.63
+1.97 (0.66%)
META  565.91
-7.11 (-1.24%)
MSFT  368.70
-4.18 (-1.12%)
NVDA  175.00
-2.64 (-1.49%)
ORCL  142.06
-3.48 (-2.39%)
TSLA  339.47
-13.35 (-3.78%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.